Related Experiment Video
Updated: Jul 26, 2025

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
Increasing Patient Access to Medical Cannabis Requires Federal Legislation
Noelene Johnson1, Danielle Gordon
1Noelene Johnson is a clinical nurse specialist in the Department of Anesthesia Pain Services and Danielle Gordon is an assistant general counsel and institutional compliance manager in the Office of Corporate Compliance, both at Memorial Sloan Kettering Cancer Center (MSKCC), New York City. Gordon is also a partner in a cannabis processing and manufacturing company. Contact author: Noelene Johnson, johnson2@mskcc.org . The views expressed here are those of the authors and do not represent those of MSKCC. The authors have disclosed no other potential conflicts of interest, financial or otherwise.
Abstract:
Marijuana's Schedule I classification remains an obstacle.
Related Concept Videos
Standards of Care I
Standards of Care II
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

